Of the 30 companies in the index, 25 saw their share prices increase and four saw their stock prices decline, while one company was flat month over month.
The blood-based test is intended to aid in the decision for prostate biopsy for men older than 50 with elevated PSA levels.
Abbott CEO Robert Ford called cancer testing a "critically important market" that the firm has made a priority to move into.
NEW YORK – The US Food and Drug Administration granted 510(k) marketing clearances in October to Becton Dickinson, Diasorin, Visby Medical, and others for pathogen detection assays and other in vitro ...
The agency would down-classify nucleic acid-based tests for use with a corresponding approved therapy product to Class II devices from Class III.
InnotiveDx's UTI diagnostic technology provides bacterial identification and antimicrobial susceptibility test results in less than 60 minutes.
NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...
NEW YORK — Clinical informatics firm Ovation.io has partnered with PrecisionLife to develop a test that can identify individuals likely to respond to glucagon-like peptide-1 receptor agonist (GLP-1) ...
The pre-Series A funding round was led by Spectrum Impact with participation from the founders and existing investors including Vijay Alreja Family Office.
NEW YORK – Agilent Technologies said after the close of the market Monday that its fiscal fourth quarter revenues grew 9 percent year over year. For the three months ended Oct. 31, the Santa Clara, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback